Pyronaridine Protects against SARS-CoV-2 Infection in Mouse-Reference-Cited by-同舟云学术

Pyronaridine Protects against SARS-CoV-2 Infection in Mouse

Published:2022-05-24 Issue:6 Volume:8 Page:1147-1160
ISSN:2373-8227
Container-title:ACS Infectious Diseases
language:en
Short-container-title:ACS Infect. Dis.

Author:

Puhl Ana C.¹^ORCID,Gomes Giovanni F.²,Damasceno Samara²,Godoy Andre S.³,Noske Gabriela D.³,Nakamura Aline M.³,Gawriljuk Victor O.³,Fernandes Rafaela S.³,Monakhova Natalia⁴,Riabova Olga⁴,Lane Thomas R.¹,Makarov Vadim⁴,Veras Flavio P.²,Batah Sabrina S.⁵,Fabro Alexandre T.⁵,Oliva Glaucius³,Cunha Fernando Q.²,Alves-Filho José C.²,Cunha Thiago M.²,Ekins Sean¹^ORCID

Affiliation:

1. Collaborations Pharmaceuticals, Inc., 840 Main Campus Drive, Lab 3510, Raleigh, North Carolina 27606, United States

2. Center for Research in Inflammatory Diseases (CRID), Ribeirao Preto Medical School, University of São Paulo, Avenida Bandeirantes, 3900, Ribeirao Preto 14049-900, São Paulo, Brazil

3. Institute of Physics of Sao Carlos, University of São Paulo, Av. Joao Dagnone, 1100 - Jardim Santa Angelina, Sao Carlos 13563-120, Brazil

4. Research Center of Biotechnology RAS, Leninsky prospect, 33, Building 2, 119071 Moscow, Russia

5. Department of Pathology and Legal Medicine, Ribeirão Preto Medical School, University of São Paulo, Avenida Bandeirantes, 3900, Ribeirao Preto 14049-900, São Paulo, Brazil

Funder

National Center for Complementary and Alternative Medicine

National Institute of Allergy and Infectious Diseases

Russian Foundation for Basic Research

Funda??o Amaz?nia Paraense de Amparo ? Pesquisa

Funda??o de Amparo ? Pesquisa do Estado de S?o Paulo

National Institute of General Medical Sciences

Coordena??o de Aperfei?oamento de Pessoal de N?vel Superior

Publisher

American Chemical Society (ACS)

Subject

Infectious Diseases

Link

https://pubs.acs.org/doi/pdf/10.1021/acsinfecdis.2c00091

Reference83 articles.

1. Author Correction: A new coronavirus associated with human respiratory disease in China

2. The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2

3. WHO Naming the coronavirus disease (COVID-2019) and the virus that causes it. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/naming-the-coronavirus-disease-(covid-2019)-and-the-virus-that-causes-it.

4. Novel coronavirus disease (COVID-19) pandemic: A recent mini review

5. SARS-CoV-2 vaccines strategies: a comprehensive review of phase 3 candidates

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oral Pyronaridine Tetraphosphate Reduces Tissue Presence of Parasites in a Mouse Model of Chagas Disease;ACS Omega;2024-08-20

2. PBPK‐led assessment of antimalarial drugs as candidates for Covid‐19: Simulating concentrations at the site of action to inform repurposing strategies;Clinical and Translational Science;2024-07

3. Arylamines QSAR-Based Design and Molecular Dynamics of New Phenylthiophene and Benzimidazole Derivatives with Affinity for the C111, Y268, and H73 Sites of SARS-CoV-2 PLpro Enzyme;Pharmaceuticals;2024-05-09

4. Identification of SARS-CoV-2 Main Protease Inhibitors Using Chemical Similarity Analysis Combined with Machine Learning;Pharmaceuticals;2024-02-12

5. Review of COVID-19 Therapeutics by Mechanism: From Discovery to Approval;Journal of Korean Medical Science;2024